Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of doxazosin for PTSD-related sleep disturbance
2012-001548-23Phase 4Active
- Sponsor
- Parnassia Groep
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of doxazosin in post-traumatic stress disorder (PTSD), sponsored by Parnassia Groep. Primary endpoint: Sleep parameters. Started Aug 2012; status: active.
02
Drugs
doxazosin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2012-001548-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001548-23.